Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 4, Number 4—December 1998
Synopsis

Rotavirus

Umesh D. ParasharComments to Author , Joseph S. Bresee, Jon R. Gentsch, and Roger I. Glass
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 4

Distribution of rotavirus strains from a global collection of 2,748 strains. "Others" includes strains that were not typable. Adapted from (11).

Figure 4. Distribution of rotavirus strains from a global collection of 2,748 strains. "Others" includes strains that were not typable. Adapted from (11).

Main Article

References
  1. Bishop  RF, Davidson  GP, Holmes  IH, Ruck  BJ. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet. 1973;1:12813. DOIGoogle Scholar
  2. de Zoysa  I, Feachem  RV. Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunisation. Bull World Health Organ. 1985;63:56983.PubMedGoogle Scholar
  3. Kapikian  AZ, Chanock  RM. Rotaviruses. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Monath TP, Melnick JL, et al., editors. Fields virology, 3rd ed. Vol. 2. New York: Raven Press; 1996: p. 1657-708.
  4. Estes  MK. Rotaviruses and their replication. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Monath TP, Melnick JL, et al, editors. Fields virology, 3rd ed. Vol. 2. New York: Raven Press; 1996. p. 1625-55.
  5. Parashar  UD, Holman  RC, Clarke  MJ, Bresee  JS, Glass  RI. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus specific diagnostic code. J Infect Dis. 1998;177:713. DOIGoogle Scholar
  6. Tucker  AW, Haddix  AC, Bresee  JS, Holman  RC, Parashar  UD, Glass  RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA. 1998;279:13716. DOIPubMedGoogle Scholar
  7. Institute of Medicine. The prospects of immunizing against rotavirus. In: New vaccine development: diseases of importance in developing countries, Vol. 2. Washington: National Academy Press; 1986. p. D-13 to D-13-2.
  8. Glass  RI, Bresee  JS, Parashar  UD, Miller  MA, Gentsch  JR. Rotavirus vaccines at the threshold. Nat Med. 1997;3:101. DOIGoogle Scholar
  9. Bishop  RF, Barnes  GL, Cipriani  E, Lund  JS. Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N Engl J Med. 1983;309:726.PubMedGoogle Scholar
  10. Velazquez  FR, Matson  DO, Calva  JJ, Guerrero  ML, Morrow  AL, Carter-Campbell  S, Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335:10228. DOIPubMedGoogle Scholar
  11. Gentsch  JR, Woods  PA, Ramachandran  M, Das  BK, Leite  JP, Alfieri  A, Review of G and P typing results from a global collection of rotavirus strains: implication for vaccine development. J Infect Dis. 1996;174:S306.PubMedGoogle Scholar
  12. Ramachandran  M, Das  BK, Vij  A, Kumar  R, Bhambal  SS, Kesari  N, Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microbiol. 1996;34:4369.PubMedGoogle Scholar
  13. Cicirello  HG, Das  BK, Gupta  A, Bhan  MK, Gentsch  JR, Kumar  R, High prevalence or rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus. Pediatr Infect Dis J. 1994;13:7204. DOIPubMedGoogle Scholar
  14. Cook  SM, Glass  RI, LeBaron  CW, Ho  M-S. Global seasonality of rotavirus infections. Bull World Health Organ. 1990;68:1717.PubMedGoogle Scholar
  15. Török  TJ, Kilgore  PE, Clarke  MJ, Holman  RC, Bresee  JS, Glass  RI. Visualizing geographic and temporal trends in rotavirus activity in the United States, 1991 to 1996. Pediatr Infect Dis J. 1997;16:9416. DOIPubMedGoogle Scholar
  16. Nakagomi  O, Nakagomi  T. Genetic diversity and similarity among mammalian rotaviruses in relation to interspecies transmission of rotavirus. Arch Virol. 1991;120:4355. DOIPubMedGoogle Scholar
  17. Ward  R. Mechanisms of protection against rotavirus in humans and mice. J Infect Dis. 1996;174:S518.PubMedGoogle Scholar
  18. Offit  PA. Host factors associated with protection against rotavirus disease: the skies are clearing. J Infect Dis. 1996;174:S5964.PubMedGoogle Scholar
  19. Ebina  T, Sato  A, Umezu  K, Ishida  N, Ohyama  S, Ohizumi  A, Prevention of rotavirus infection with cow colostrum containing antibody against human rotavirus. Lancet. 1983;2:102930. DOIPubMedGoogle Scholar
  20. Hilpert  H, Brussow  H, Mietens  C, Sidoti  J, Lerner  L, Werchau  H. Use of bovine milk concentrate antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis. 1987;156:15866.PubMedGoogle Scholar
  21. Kapikian  AZ. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea in infants and young children: an introduction. In: Kapikian AZ, editor. Viral infections of the gastrointestinal tract. Vol 2. New York: Marcel Dekker; 1994. p. 409-17.
  22. Vesikari  T, Isolauri  E, d'Hondt  E. Protection of infants against rotavirus diarrhea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet. 1984;1:97781. DOIPubMedGoogle Scholar
  23. Vesikari  T, Isolauri  E, Delem  A, d'Hondt  E, Andre  FE, Beards  GM, Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr. 1985;107:18994. DOIPubMedGoogle Scholar
  24. Vesikari  T, Ruuska  T, Delem  A, Andre  FE, Beards  GM, Flewett  TH. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine (at birth and 7 months of age) for prevention of rotavirus diarrhea. Acta Paediatr Scand. 1991;80:17380. DOIPubMedGoogle Scholar
  25. Ruuska  T, Vesikari  T, Delem  A, Andre  FE, Beards  GM, Flewett  TH. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy and season of birth in relation to rotavirus epidemic period. Scand J Infect Dis. 1990;22:26978. DOIPubMedGoogle Scholar
  26. Santosham  M, Letson  WG, Wolff  M, Reid  R, Gahagan  S, Adams  R, A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis. 1991;163:4837.PubMedGoogle Scholar
  27. Hanlon  P, Hanlon  L, Marsh  V, Byass  P, Shenton  F, Hassan-King  M, Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet. 1987;1:13425. DOIPubMedGoogle Scholar
  28. DeMol  P, Zissis  G, Butzler  JP, Mutwewingabo  A, Andre  FE. Failure of live, attenuated oral rotavirus vaccine. Lancet. 1986;1:108. DOIPubMedGoogle Scholar
  29. Lanata  CF, Black  RE, del Aguila  R, Gil  A, Verastegui  H, Gerna  G, Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis. 1989;159:4529.PubMedGoogle Scholar
  30. Clark  HF, Borian  FE, Bell  LM, Plotkin  SA. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis. 1988;158:57087.PubMedGoogle Scholar
  31. Bernstein  DI, Smith  VE, Sander  DS, Pax  KA, Schiff  GM, Ward  RL. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis. 1990;162:105562.PubMedGoogle Scholar
  32. Georges-Courbot  MC, Monges  J, Siopathis  MR, Roungou  JB, Gresenguet  G, Bellec  L, Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol. 1991;142:40511. DOIPubMedGoogle Scholar
  33. Rennels  MB, Losonsky  GA, Levine  MM, Kapikian  AZ. Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children. Pediatr Infect Dis J. 1986;5:5878. DOIGoogle Scholar
  34. Gothefors  L, Wadell  G, Juto  P, Taniguchi  K, Kapikian  AZ, Glass  RI. Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J Infect Dis. 1989;159:7537.PubMedGoogle Scholar
  35. Christy  C, Madore  HP, Pichichero  ME, Gala  C, Pincus  P, Vosefsky  D, Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J. 1988;7:64550. DOIPubMedGoogle Scholar
  36. Rennels  MB, Losonsky  GA, Young  AE, Shindledecker  CL, Kapikian  AZ, Levine  MM. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The clinical study group. Am J Dis Child. 1990;144:6014.PubMedGoogle Scholar
  37. Vesikari  T, Rautenen  T, Varis  T, Beards  GM, Kapikian  AZ. Rhesus rotavirus candidate vaccine. Am J Dis Child. 1990;144:2859.PubMedGoogle Scholar
  38. Madore  HP, Christy  C, Pichichero  M, Long  C, Pincus  P, Vosefsky  D, Field trial of rhesus rotavirus or human-rhesus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. J Infect Dis. 1992;166:23543.PubMedGoogle Scholar
  39. Perez-Schael  I, Garcia  D, Gonzalez  M, Gonzalez  R, Daoud  N, Perez  M, Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol. 1990;30:21929. DOIPubMedGoogle Scholar
  40. Kapikian  AZ, Hoshino  Y, Chanock  RM, Perez-Schael  I. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis. 1996;174:S6572.PubMedGoogle Scholar
  41. Perez-Schael  I, Guntinas  MJ, Perez  M, Pagone  V, Rojas  AM, Gonzlez  R, Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med. 1997;337:11817. DOIPubMedGoogle Scholar
  42. Joensuu  J, Koskenniemi  E, Pang  X-L, Vesikari  T. A randomized, double-blind placebo controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet. 1997;350:12059. DOIPubMedGoogle Scholar
  43. Rennels  MB, Glass  RI, Dennehy  PH, Bernstein  DI, Pichichero  ME, Zito  PT, Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines-report of the national multicenter trial. Pediatrics. 1996;97:713.PubMedGoogle Scholar
  44. Santosham  M, Moulton  LH, Reid  R, Croll  J, Weatherholt  R, Ward  R, Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr. 1997;131:6328. DOIPubMedGoogle Scholar
  45. Bernstein  DI, Glass  RI, Rodgers  G, Davidson  BL, Sack  DA; U.S. Rotavirus Vaccine Efficacy Group. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S. children. JAMA. 1995;273:11916. DOIPubMedGoogle Scholar
  46. Lanata  CF, Midthun  K, Black  RE, Lazo  F, Butron  B, Linares  A, Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis. 1996;174:26875.PubMedGoogle Scholar
  47. Linhares  AC, Gabbay  YB, Mascarenhas  JDP, deFreitas  RB, Oliveira  CS, Bellesi  N, Immunogenicity, safety, and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull World Health Organ. 1996;74:491500.PubMedGoogle Scholar
  48. Clark  HF, Offit  PA, Ellis  RW, Eiden  JJ, Krah  D, Shaw  AR, The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis. 1996;174:S7380.PubMedGoogle Scholar
  49. Vesikari  T, Ruuska  T, Koivu  H, Green  KY, Flores  J, Kapikian  AZ. Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. Pediatr Infect Dis J. 1991;10:9127.PubMedGoogle Scholar
  50. Connor  ME, Zarley  CD, Hu  B, Parsons  S, Drabinski  D, Greiner  S, Virus-like particles as a rotavirus subunit vaccine. J Infect Dis. 1996;174:S8892.PubMedGoogle Scholar
  51. Herrmann  JE, Chen  SC, Fynan  EF, Santoro  JC, Greenberg  HB, Wang  S, Protection against rotavirus infections by DNA vaccination. J Infect Dis. 1996;174:S937.PubMedGoogle Scholar
  52. Hausdorff  WP. Prospects for the use of new vaccines in developing countries: cost is not the only impediment. Vaccine. 1996;14:117986. DOIPubMedGoogle Scholar

Main Article

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external